Venezuela Medical Device Regulation: RIF Registration and Local Sanitary Licence
Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
To carry out any import or registration procedure in Venezuela, the entity must complete two layers of registration: the Single Tax Information Registry (RIF, Registro Único de Información Fiscal) with the National Integrated Customs and Tax Administration (SENIAT), and a local sanitary licence. Both are preconditions for opening a COMEX platform account and for every procedure that follows.
The conclusion is that the order in which entity documents are assembled cannot be inverted: a legally constituted entity comes first, then the RIF and the sanitary licence, and only then the platform account. Since the platform became mandatory in 2025, this sequence has moved from an internal management preference to a hard system check. Miss one step and the filing cannot be submitted at all, regardless of how complete the product dossier is.
A second conclusion follows from the first. Because the checks are automated, an entity whose documents are valid but misaligned, for example a licence issued to a predecessor company name or a RIF whose activity code does not cover the product class, will fail at the platform gate rather than at substantive review. Rectifying the entity file is therefore on the critical path of the registration timeline, and it should be scheduled before any dossier work is commissioned.
A further point concerns evidence. A platform check accepts a document that exists and is current; it does not accept an explanation that a document is being processed. Where an entity file is incomplete, the honest planning assumption is that no filing can be made until the gap closes, and that the gap should be closed before the product dossier is commissioned rather than in parallel with it.
2. Legal basis
The instruments below establish the registration duties and the platform requirement. Citations are reproduced exactly as they appear in the Venezuelan and third-party sources.
| Instrument | Reference | Publication date | Provision / key point |
|---|---|---|---|
| Código Orgánico Tributario (Organic Tax Code) | Currently in force | — | Legal basis for RIF registration and taxpayer duties |
| Ley del IVA (VAT Law) | Currently in force | — | RIF registration required as soon as taxable activity begins |
| Circular N° DGSACS/0002/2025 | DGSACS/0002/2025 | 28 October 2025 | Procedures in all three directorate streams handled through the COMEX platform |
| USDA GAIN report VE2026-0007 | VE2026-0007 | July 2026 | Firms must complete COMEX registration and the corresponding company registration, otherwise customs refuses the cargo |
Source note: the COMEX registration requirement is taken from the USDA Foreign Agricultural Service GAIN report (VE2026-0007, July 2026), a third-party official source. The legal basis for the RIF and for the local sanitary licence lies in Venezuelan tax and health legislation.
3. Expert insights
Insight 1: COMEX registration is a mandatory step added after 2025. The GAIN report states plainly that firms must register all products on COMEX, the central digital platform of the Ministry of Finance, and obtain the corresponding company registration, failing which customs will refuse the goods. This requirement corroborates Circular DGSACS/0002/2025 from the other direction: the circular connects SACS procedures to COMEX, while the report explains that COMEX itself is the registration gateway for any company engaging in import or export. Read together, the two establish that no product-level approval can compensate for a missing entity-level registration.
Insight 2: the RIF duty starts when taxable activity begins, not when revenue appears. Under the Venezuelan VAT framework, taxable activity triggers RIF registration from the moment it commences. For an authorized representative this means the duty arises when the representation agreement is signed and registration work starts, well before the first consignment arrives. Entities that defer registration until they have something to declare create a gap in which invoices cannot be properly issued and platform steps cannot be completed, and the gap is usually discovered at the least convenient moment.
Insight 3: the local sanitary licence is a second layer of registration, independent of the RIF. Comparative industry material confirms that Venezuela requires the company’s local sanitary licence. That licence certifies the entity’s eligibility to carry out activities connected with sanitary products, which is a different question from tax standing, is assessed by a different authority, and is verified through a different document set. A company can hold a perfectly valid RIF and still be unable to file, because the sanitary licence is missing, expired or issued for a different activity scope.
Insight 4: the validity periods of entity documents are easily overlooked. The company registration, the RIF and the sanitary licence each carry their own renewal requirements, and the cycles do not coincide. All three must be simultaneously valid at the moment of filing. If any one lapses during review, the procedure stalls, and in a platform environment a stalled file may lose its queue position or require resubmission. Monitoring three separate expiry dates is a small administrative task with an outsized effect on schedule.
4. Practical recommendations
- Work through the five steps in order: legal establishment, RIF registration, local sanitary licence, COMEX registration, platform account. Obtain written evidence at each step before starting the next.
- Before signing with an authorized representative, verify the validity of its RIF and sanitary licence, not only its certificate of incorporation.
- Maintain an expiry ledger for entity documents and set the warning threshold against the earliest expiry in the set, not against each document separately.
- If the manufacturer establishes its own Venezuelan entity to act as holder, budget adequate time for all five steps, since incorporation and registration run on their own clock and cannot be compressed by paying more.
- Re-verify the entity file at each new product filing rather than assuming that documents accepted last year are still current.
5. Verification checklist
- □ The authorized representative’s legal establishment documents have been verified and are within validity
- □ RIF registration is complete and the certificate of registration is on file
- □ The local sanitary licence has been obtained and is within validity
- □ COMEX platform registration and the account are activated
- □ An expiry ledger for entity documents has been established with warning thresholds
Regulatory information verified as of October 29, 2026.
GRZAN supports medical device manufacturers, importers and authorized representatives with registration work in Venezuela, from entity qualification and RIF and sanitary licence verification through COMEX registration and platform onboarding. Whether you need a document gap review or hands-on filing support, our regulatory team can help. Contact us at info@grzanglobal.com.
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us